| Literature DB >> 25500547 |
Alexander Cecil1, Knut Ohlsen2, Thomas Menzel2, Patrice François3, Jacques Schrenzel3, Adrien Fischer3, Kirsten Dörries4, Martina Selle2, Michael Lalk4, Julia Hantzschmann2, Marcus Dittrich1, Chunguang Liang1, Jörg Bernhardt5, Tobias A Ölschläger2, Gerhard Bringmann6, Heike Bruhn2, Matthias Unger7, Alicia Ponte-Sucre8, Leane Lehmann7, Thomas Dandekar9.
Abstract
Isoquinolines (IQs) are natural substances with an antibiotic potential we aim to optimize. Specifically, IQ-238 is a synthetic analog of the novel-type N,C-coupled naphthylisoquinoline (NIQ) alkaloid ancisheynine. Recently, we developed and tested other IQs such as IQ-143. By utilizing genome-wide gene expression data, metabolic network modelling and Voronoi tessalation based data analysis - as well as cytotoxicity measurements, chemical properties calculations and principal component analysis of the NIQs - we show that IQ-238 has strong antibiotic potential for staphylococci and low cytotoxicity against murine or human cells. Compared to IQ-143, systemic effects are less pronounced. Most enzyme activity changes due to IQ-238 are located in the carbohydrate metabolism. Validation includes metabolite measurements on biological replicates. IQ-238 delineates key properties and a chemical space for a good therapeutic window. The combination of analysis methods allows suggestions for further lead development and yields an in-depth look at staphylococcal adaptation and network changes after antibiosis. Results are compared to eukaryotic host cells.Entities:
Keywords: Extreme pathway analysis; Gene expression; Infection; Metabolism; Metabolites; Principal component analysis; Voronoi tessalation
Mesh:
Substances:
Year: 2014 PMID: 25500547 DOI: 10.1016/j.ijmm.2014.11.006
Source DB: PubMed Journal: Int J Med Microbiol ISSN: 1438-4221 Impact factor: 3.473